Home › Markets › Health Care › XBIT

XBiotech Inc. (XBIT)

XBIT trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · October 14, 2026
$2.16
-5.68% on the day
Market cap
$65.9M
Micro cap
Revenue
No annual revenue filed since the period ending 2023-12-31
Net income
No annual revenue filed since the period ending 2023-12-31

Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.

Profile

FieldValue
TickerXBIT on Nasdaq
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountryUnited States
IPO year2015
SEC CIK0001626878
SEC industry codePharmaceutical Preparations
Incorporated inA1

Financials

No annual revenue filed since the period ending 2023-12-31.

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document
FORM 424B5
424B52019-06-03
Latest annual report
FORM 10-K/A
10-K/A2026-04-29
Latest quarterly / interim
FORM 10-Q
10-Q2026-08-13
Latest current report
FORM 8-K
8-K2025-12-09
Latest proxy
FORM DEF 14A
DEF 14A2026-10-02

Source: SEC EDGAR submissions feed, 403 recent filings. All filings on EDGAR.

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
RNTXRein Therapeutics Inc.$0.7546-3.86%$65.1M
FBIOFortress Biotech Inc.$1.95-7.58%$65.0M
SPROSpero Therapeutics Inc.$1.15-2.54%$67.0M
SDEVStablecoin Development Corporation$1.25-11.35%$64.7M
OSTXOS Therapies Incorporated$1.45-7.05%$67.4M
ONCYOncolytics Biotech Inc.$0.4900+3.53%$64.2M
CINGCingulate Inc.$4.72-2.48%$68.6M
NMADNomad Power Solutions Inc.$4.28+2.64%$68.9M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier